MoneyWorks4Me

The Sales for the quarter ended June 2024 of Rs. 304.56 million declined by -89.81% from Rs. 2990.06 millions.The Company to register a -63.70%  fall in the net profit for the quarter ended June 2024.The company reported a degrowth in operating Profit to 66.07 millions from 653.67 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 304.56 2990.06 -89.81 304.56 2990.06 -89.81 12273.18 11519.57 6.54
Other Income 111.39 55.53 100.59 111.39 55.53 100.59 453.14 332.82 36.15
PBIDT 66.07 653.67 -89.89 66.07 653.67 -89.89 2952.81 2553.74 15.63
Interest 1.69 203.84 -99.17 1.69 203.84 -99.17 510.96 921.66 -44.56
PBDT 64.38 449.83 -85.69 64.38 449.83 -85.69 6307.75 1365.60 361.90
Depreciation 2.50 138.85 -98.20 2.50 138.85 -98.20 533.03 573.62 -7.08
PBT 61.88 310.98 -80.10 61.88 310.98 -80.10 5774.72 791.98 629.15
TAX 0.00 140.49 0.00 0.00 140.49 0.00 1590.81 367.25 333.17
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -108.43 233.61 -146.41
PAT 61.88 170.49 -63.70 61.88 170.49 -63.70 4183.91 424.73 885.08
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 21.69 21.86 -0.77 21.69 21.86 -0.77 24.06 22.17 8.53
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..